Violates headline rule
True, but otherwise it would seem like a free ad for a future troll.
I started a genome software company that primarily targets the academic research market, but we recently adapted our software for 23andMe users: https://www.enlis.com/personal_edition.html
Happy to hear opinions and bug reports!